首页> 外文期刊>International Journal of Pharmaceutics >Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats
【24h】

Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-/-) Sprague Dawley rats

机译:聚山梨酯20增加野生型Sprague Dawley大鼠的地高辛口服吸收,但不影响mdr1a(-/-)Sprague Dawley大鼠的口服地高辛吸收

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim was to investigate the ability of polysorbate 20 to alter oral digoxin absorption in vitro and drug exposure in vivo via modulation of transporter mediated efflux. Transport studies were performed in MDCKII-MDR1 and Caco-2 cells using H-3-digoxin. Pharmacokinetic studies were performed in wild type and mdr1a deficient Sprague Dawley rats. H-3-digoxin was quantified using liquid scintillation counting. The results showed an increased absorptive transport and a reduced secretory transport in MDCKII-MDR and Caco-2 cells as a function of polysorbate 20 concentrations. The secretory transport (B-A) of digoxin was reduced by 50% at lower polysorbate 20 concentrations than required to increase the absorptive transport (A-B). In vivo, the oral bioavailability of digoxin in wild type animal was increased by 10-25% (w/v) polysorbate 20. In mdr1a deficient Sprague Dawley rats 25% (w/v) polysorbate 20 did not alter the absorption of digoxin after oral administration, but digoxin exposure was significantly different between wild type and mdr1a deficient rats. In conclusion, polysorbate 20 increased absorptive transport across Caco-2 cell monolayers and in vivo in rats in a concentration dependent manner, most likely via inhibition of P-gp rather than through solubilization of digoxin. (C) 2016 Elsevier B.V. All rights reserved.
机译:目的是研究聚山梨酯20通过调节转运蛋白介导的外排改变体外口服地高辛吸收和体内药物暴露的能力。使用H-3-digoxin在MDCKII-MDR1和Caco-2细胞中进行转运研究。在野生型和mdr1a缺陷的Sprague Dawley大鼠中进行了药代动力学研究。使用液体闪烁计数对H-3-地高辛进行定量。结果表明,随着聚山梨酯20浓度的增加,MDCKII-MDR和Caco-2细胞的吸收转运增加,分泌转运减少。地高辛的分泌转运(B-A)在聚山梨酯20浓度较低时比增加吸收转运(A-B)所需浓度降低了50%。在体内,地高辛在野生型动物中的口服生物利用度提高了10-25%(w / v)聚山梨醇酯20。在缺乏mdr1a的Sprague Dawley大鼠中,25%(w / v)聚山梨醇酯20不会改变地高辛的吸收。口服,但野生型和mdr1a缺乏大鼠之间的地高辛暴露显着不同。总之,聚山梨酯20以浓度依赖的方式增加了跨Caco-2细胞单层和大鼠体内的吸收性转运,这很可能是通过抑制P-gp而不是通过地高辛的增溶。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号